Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

Christopher M. Jackson(Johns Hopkins University), Michael Lim(Stanford University)
Clinical and Developmental Immunology
January 1, 2011
10.1155/2011/732413
Cited by 147

Related Papers

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
|PLoS ONE|2014|236
A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
|Cancers|2019|104